top of page
kirabio-hero-4.png

KiraLOGIC: AI That Learns From Real Biology

kirabio-hero-1.jpg

AI trained on real function, not static readouts

 

KiraLOGIC is our AI-powered platform that designs multiplex edits to keep immune cells functional under tumor microenvironment (TME) pressure.

 

It learns directly from real phenotypes — cytotoxicity, cytokine release, RNA-seq, and persistence in 3D tumor models — so our designs reflect how cells actually behave, not just what they express.

How It Works

kgb-diagram-mcl-1.png
kgb-diagram-mcl-2b.png
kgb-diagram-mcl-3b.png

‘Intervention’ includes gene edit combinations applied to cells.

Outputs shown are representative, not exhaustive

  1. Design — Generate candidate edit sets matched to each tumor’s dominant suppression modes.

  2. Test — Run multiplex assays in suppression-rich models (spheroids, organoids, xenografts).

  3. Learn & Select — The model ranks combinations for durability and nominates the next in vivo candidates. 

Why It Matters

  • Fewer cycles → compress discovery time

  • Better combinations → multi-pathway protection by design

  • Scales broadly → applies across T, NK, and γδ T cells 

The KiraLOGIC Flywheel

Smarter with every dataset. Stronger with every program. Every experiment trains KiraLOGIC—powering smarter, more durable cell therapies.

flywheel.png

Foundation

GBM Program validates TME resistance logic

Acceleration

Accelerates application across tumor types

Scale

The same protection scales across cell types

Moat

Every dataset sharpens predictions & defensibility

kgb-platform-3.png
kgb-platform-2.png
kgb-platform-1.png
kgb-platform-4.png

KiraLOGIC is how we design to cure

— and build to endure.

bottom of page